Partnership Opportunities

Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the limited partnership opportunities available for the 2024 event, please get in touch at sponsor@hansonwade.com

The 3rd ADC Target Selection Summit was the only industry-specific forum providing the industry with scientific and strategic insights to transform ADC target selection by identifying novel and repurposing clinically validated targets.

Over 100+ attendees were in the room from Seagen, AstraZeneca, Merck, Zymeworks, AbbVie, Bolt Biotherapeutics, and many more; who are working exclusively in biology, discovery, translational, target identification and validation.

Don’t miss this opportunity to gain unparallel visibility to this audience looking for partnerships and collaborations that can aid them to better inform target selection and balance risk in ADC pipelines to progress them into the clinic and ultimately to market.

What You Missed

  • Meet your 2023 commercial objectives and educate decision-makers on how your expertise can help ADC developers progress their drugs to clinic, and ultimately to market
  • Showcase your expertise to leading ADC developers by securing an exhibition booth to set yourself as to go-to service provider in the ADC target community
  • Demonstrate thought leadership and drive brand exposure by securing a speaking slot on the agenda to connect with the community and generate partnerships
  • Maximize the balance of content and networking to generate leads and build new relationships with industry pioneers

What Are ADC Target Experts Seeking?

https://adc-targetselection.com/wp-content/uploads/sites/558/2023/07/cropped-33236-ADC-Target-Selection-Summit-Logo_FINAL-90x90-1.png

Antibody Providers: ADC developers with expertise in target selection are looking to partner with high-quality antibody discovery or manufacturing organizations to complement their target of choice and in-license antibodies

https://adc-targetselection.com/wp-content/uploads/sites/558/2023/07/cropped-33236-ADC-Target-Selection-Summit-Logo_FINAL-90x90-1.png

Immunohistochemistry (IHC): IHC providers are necessary for ADC developers to see how their drug is binding with the desired target in a preclinical setting. ADC target specialists are looking to find highly specialized IHC providers to outsource this stage of their development

https://adc-targetselection.com/wp-content/uploads/sites/558/2023/07/cropped-33236-ADC-Target-Selection-Summit-Logo_FINAL-90x90-1.png

Proteomics Experts: Proteomic analysis is a necessary step in ADC's early development to identify and validate targets while gaining information on efficacy and toxicity. For this vital step of early development, ADC target experts are looking for Proteomic masterminds who can complete this work in concordance with strict quality standards

https://adc-targetselection.com/wp-content/uploads/sites/558/2023/07/cropped-33236-ADC-Target-Selection-Summit-Logo_FINAL-90x90-1.png

Other Services: If you have a product or service that can be beneficial to the antibody-drug conjugate industry, our attendees would love to hear about it.

If you are an industry leader in any of the above, make sure to showcase your services and form new connections and partnerships at this unique and focused forum.